These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 10523846

  • 1. Opposite transcriptional activity between the wild type c-myc gene coding for c-Myc1 and c-Myc2 proteins and c-Myc1 and c-Myc2 separately.
    Batsché E, Crémisi C.
    Oncogene; 1999 Oct 07; 18(41):5662-71. PubMed ID: 10523846
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
    Batsché E, Lipp M, Cremisi C.
    Oncogene; 1994 Aug 07; 9(8):2235-43. PubMed ID: 8036009
    [Abstract] [Full Text] [Related]

  • 3. The retinoblastoma susceptibility gene product regulates Myc-mediated transcription.
    Adnane J, Robbins PD.
    Oncogene; 1995 Jan 19; 10(2):381-7. PubMed ID: 7838535
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
    Kinney EL, Tanida S, Rodrigue AA, Johnson JK, Tompkins VS, Sakamuro D.
    J Cell Physiol; 2008 Sep 19; 216(3):621-31. PubMed ID: 18348166
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.
    Flajolet M, Gegonne A, Ghysdael J, Tiollais P, Buendia MA, Fourel G.
    Oncogene; 1997 Aug 28; 15(9):1103-10. PubMed ID: 9285565
    [Abstract] [Full Text] [Related]

  • 7. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q, Li J, Cenkci B, Kretzner L.
    Oncogene; 2004 Feb 05; 23(5):1088-97. PubMed ID: 14716294
    [Abstract] [Full Text] [Related]

  • 8. Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc.
    Mazure NM, Chauvet C, Bois-Joyeux B, Bernard MA, Nacer-Chérif H, Danan JL.
    Cancer Res; 2002 Feb 15; 62(4):1158-65. PubMed ID: 11861398
    [Abstract] [Full Text] [Related]

  • 9. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R, Chen JM, Huard S, Wang E.
    J Cell Biochem; 2005 Dec 01; 96(5):1071-85. PubMed ID: 16167342
    [Abstract] [Full Text] [Related]

  • 10. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE.
    Oncogene; 2001 Mar 29; 20(14):1688-702. PubMed ID: 11313917
    [Abstract] [Full Text] [Related]

  • 11. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells.
    Kim DW, Gazourian L, Quadri SA, Romieu-Mourez R, Sherr DH, Sonenshein GE.
    Oncogene; 2000 Nov 16; 19(48):5498-506. PubMed ID: 11114727
    [Abstract] [Full Text] [Related]

  • 12. Bax is a transcriptional target and mediator of c-myc-induced apoptosis.
    Mitchell KO, Ricci MS, Miyashita T, Dicker DT, Jin Z, Reed JC, El-Deiry WS.
    Cancer Res; 2000 Nov 15; 60(22):6318-25. PubMed ID: 11103792
    [Abstract] [Full Text] [Related]

  • 13. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
    Yang J, Deng X, Deng L, Gu H, Fan W, Cao Y.
    J Exp Clin Cancer Res; 2004 Sep 15; 23(3):495-506. PubMed ID: 15595642
    [Abstract] [Full Text] [Related]

  • 14. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C, Chen N, Sawadogo M.
    Exp Cell Res; 2005 Jan 01; 302(1):1-10. PubMed ID: 15541720
    [Abstract] [Full Text] [Related]

  • 15. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2.
    Batsché E, Muchardt C, Behrens J, Hurst HC, Crémisi C.
    Mol Cell Biol; 1998 Jul 01; 18(7):3647-58. PubMed ID: 9632747
    [Abstract] [Full Text] [Related]

  • 16. Activation of gene transcription by the amino terminus of the N-Myc protein does not require association with the protein encoded by the retinoblastoma suppressor gene RB1.
    Cziepluch C, Wenzel A, Schürmann J, Schwab M.
    Oncogene; 1993 Oct 01; 8(10):2833-8. PubMed ID: 8378092
    [Abstract] [Full Text] [Related]

  • 17. A novel factor distinct from E2F mediates C-MYC promoter activation through its E2F element during exit from quiescence.
    Alvaro-Blanco J, Martínez-Gac L, Calonge E, Rodríguez-Martínez M, Molina-Privado I, Redondo JM, Alcamí J, Flemington EK, Campanero MR.
    Carcinogenesis; 2009 Mar 01; 30(3):440-8. PubMed ID: 19126644
    [Abstract] [Full Text] [Related]

  • 18. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL, Rand A, Kelm RJ, Getz MJ.
    Oncogene; 2000 Jul 13; 19(30):3352-62. PubMed ID: 10918592
    [Abstract] [Full Text] [Related]

  • 19. Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc.
    Sasaki T, Suzuki H, Yagi K, Furuhashi M, Yao R, Susa S, Noda T, Arai Y, Miyazono K, Kato M.
    Cancer Res; 2003 Feb 15; 63(4):801-6. PubMed ID: 12591729
    [Abstract] [Full Text] [Related]

  • 20. Position and orientation independent transactivation by c-Myc.
    Packham G, Bello-Fernandez C, Cleveland JL.
    Cell Mol Biol Res; 1994 Feb 15; 40(7-8):699-706. PubMed ID: 7787888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.